Quorum Health (NYSE:QHC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Thursday.

According to Zacks, “Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services. “

Several other equities analysts have also issued reports on the company. Royal Bank Of Canada reiterated a “hold” rating and issued a $5.00 price objective on shares of Quorum Health in a research report on Tuesday, October 3rd. ValuEngine upgraded Quorum Health from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Deutsche Bank boosted their price objective on Quorum Health from $3.00 to $3.50 and gave the company a “hold” rating in a research report on Monday, August 14th. Finally, Credit Suisse Group boosted their price objective on Quorum Health from $3.00 to $4.00 and gave the company a “neutral” rating in a research report on Monday, August 14th. Four investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. The company currently has a consensus rating of “Sell” and a consensus price target of $4.13.

Shares of Quorum Health (NYSE QHC) traded up $0.46 on Thursday, hitting $4.84. The company had a trading volume of 334,232 shares, compared to its average volume of 222,001. The company has a debt-to-equity ratio of 9.39, a current ratio of 1.84 and a quick ratio of 1.68. Quorum Health has a 1-year low of $2.54 and a 1-year high of $9.46.

In other news, SVP Shaheed Koury bought 10,000 shares of the business’s stock in a transaction on Monday, November 13th. The shares were purchased at an average price of $4.69 per share, for a total transaction of $46,900.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 4.70% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Simplex Trading LLC lifted its stake in Quorum Health by 470.9% in the 3rd quarter. Simplex Trading LLC now owns 19,909 shares of the company’s stock valued at $103,000 after acquiring an additional 16,422 shares in the last quarter. Sterling Capital Management LLC lifted its stake in Quorum Health by 41.6% in the 2nd quarter. Sterling Capital Management LLC now owns 26,918 shares of the company’s stock valued at $112,000 after acquiring an additional 7,909 shares in the last quarter. Citigroup Inc. lifted its stake in Quorum Health by 3.7% in the 2nd quarter. Citigroup Inc. now owns 29,080 shares of the company’s stock valued at $121,000 after acquiring an additional 1,027 shares in the last quarter. Federated Investors Inc. PA bought a new stake in Quorum Health in the 2nd quarter valued at approximately $157,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Quorum Health in the 2nd quarter valued at approximately $176,000. Hedge funds and other institutional investors own 81.68% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/12/09/zacks-investment-research-downgrades-quorum-health-qhc-to-sell.html.

Quorum Health Company Profile

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Get a free copy of the Zacks research report on Quorum Health (QHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Quorum Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.